Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Recent development of hydrogen sulfide-releasing biomaterials as novel therapies: a narrative review

Fan J., Pung E., Lin Y., Wang Q.

Narrative Review on Neuroinflammation, Chronic Wound, published in Biomater Transl (2022) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Biomater Transl (2022)
Reported sample size
—
Source database
Europe PMC
PMID
36846507
PMCID
PMC9947736
DOI
10.12336/biomatertransl.2022.04.005
Citations
10

Abstract (original English)

Hydrogen sulfide (H 2 S) has been reported as an endogenous gasotransmitter that contributes to the modulation of a myriad of biological signalling pathways, which includes maintaining homeostasis in living organisms at physiological concentrations, controlling protein sulfhydration and persulfidation for signalling processes, mediating neurodegeneration, and regulating inflammation and innate immunity, etc. As a result, researchers are actively exploring effective approaches to evaluate the properties and the distribution of H 2 S in vivo. Furthermore, the regulation of the physiological conditions of H 2 S in vivo introduces the opportunity to further study the molecular mechanisms by which H 2 S regulates cellular functions. In recent years, many H 2 S-releasing compounds and biomaterials that can deliver H 2 S to various body systems have been developed to provide sustained and stable H 2 S delivery. Additionally, various designs of these H 2 S-releasing biomaterials have been proposed to aid in the normal conduction of physiological processes, such as cardioprotection and wound healing, by modulating different signalling pathways and cell functionalities. Using biomaterials as a platform to control the delivery of H 2 S introduces the opportunity to fine tune the physiological concentration of H 2 S in vivo, a key to many therapeutic applications. In this review, we highli

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research